Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-24 @ 3:54 PM
NCT ID:
NCT05167292
Eligibility Criteria:
Inclusion Criteria:
* adults (\>18 years) admitted to general wards of Tupua Tamasese Meaole (TTM) Hospital with a diagnosis of AKI between the 1st December 2019 and the 31st of May 2020
* serum creatinine level of \>200 micromol/L
* compliance with the current Kidney Disease Improving Global Outcomes (KDIGO) criteria for AKI diagnosis
Exclusion Criteria:
* patients on chronic haemodialysis
* patients with underlying chronic kidney disease with no evidence of AKI
* patients for whom it was not possible to ascertain a diagnosis (i.e., patients with one elevated serum creatinine result and no subsequent follow-up haematology)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05167292
Study Brief:
Protocol Section:
NCT05167292